Fluzone® Intradermal, Virus Vaccine

Reservations for the 2011-2012 season are now open to Fluzone Vaccine Partners Program members

Fluzone Intradermal vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons 18 through 64 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

Safety Information
The most common local and systemic adverse reactions to Fluzone Intradermal vaccine include erythema, induration, swelling, pain, and pruritus at the vaccination site; headache, myalgia, and malaise. Other adverse reactions may occur. Fluzone Intradermal vaccine should not be administered to anyone with a severe allergic reaction (eg, anaphylaxis) to any component of the vaccine, including egg protein, or to a previous dose of any influenza vaccine. The decision to give Fluzone Intradermal vaccine should be based on the potential benefits and risks, especially if Guillain-Barré syndrome has occurred within 6 weeks of receipt of a prior influenza vaccine. Vaccination with Fluzone Intradermal vaccine may not protect all individuals.

Before administering Fluzone Intradermal vaccine, please see full Prescribing Information.

Click here, to view the Fluzone Intradermal vaccine, Patient Information Sheet.

Fluzone and Fluzone Intradermal vaccines are manufactured and distributed by Sanofi Pasteur Inc.